Fortive FTV · NYSE
$57.79 +0.02% (+$0.01)
Summary
55 / 100 · Bulios Score
What speaks for it
- It bought back its own shares for $1.61B in the last fiscal year, 9.2% of its market value.
- Out of every 100 USD of revenue, 22 USD is left as free cash.
What to watch
- It cut its dividend by 25% last year.
- The share price is above the Bulios Fair Price.
- Analysts expect revenue to fall by 15% this fiscal year.
- Revenue fell by 4.1% a year over the last 3 years.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensiveBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 32.6 USD for 1 USD of yearly profit. Over the last five years it was 26.7 USD on average.
Valuation in detailIs it growing?
It is shrinkingRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 2.1% a year over 5 years. Over the last 3 years it fell by 4.1% a year. For the next fiscal year analysts expect revenue to fall by 15%. Earnings per share fell by 5.9% a year over the last 3 years.
Growth in detailDoes it make money?
Very wellWhere 100 USD of revenue goes
- Cost of sales 37 USD
- Research and development 6.1 USD
- Sales and administration 39 USD
- Taxes and other 5.8 USD
- Net profit 12 USD
Net profit, industry median (Hardware, Equipment & Parts) 6.6 USD
Out of every 100 USD of revenue, 12 USD is left as net profit.
Profitability in detailIs it financially healthy?
MostlyRepaying all its debt would take 3.7 years of free cash flow. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
Small, safe- Yield
- 0.43%
- Paid out of profit
- 14%
You receive $0.25 per share a year. The company covers the payout with ease.
Dividends in detailWhat do analysts expect?
Neutral- Buy 11
- Hold 17
- Sell 2
Today's price within the analysts' price targets
The average target of $63.33 is 9.6% above today's price. 37% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
- Intelligent Operating Solutions 69%
- Advanced Healthcare Solutions 31%
By region
- UNITED STATES 54%
- Countries Excluding United States and China 35%
- CHINA 10%
Intelligent Operating Solutions brings in 69% of revenue.
Segments in detail